R Squared Ltd Sells 1,070 Shares of IQVIA Holdings Inc. $IQV

R Squared Ltd reduced its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV) by 26.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,940 shares of the medical research company’s stock after selling 1,070 shares during the quarter. R Squared Ltd’s holdings in IQVIA were worth $463,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Everpar Advisors LLC lifted its holdings in shares of IQVIA by 4.6% during the second quarter. Everpar Advisors LLC now owns 1,404 shares of the medical research company’s stock valued at $221,000 after purchasing an additional 62 shares in the last quarter. Private Trust Co. NA lifted its holdings in IQVIA by 12.5% in the second quarter. Private Trust Co. NA now owns 603 shares of the medical research company’s stock valued at $95,000 after acquiring an additional 67 shares during the period. Ballentine Partners LLC lifted its holdings in IQVIA by 4.9% in the first quarter. Ballentine Partners LLC now owns 1,477 shares of the medical research company’s stock valued at $260,000 after acquiring an additional 69 shares during the period. Independent Advisor Alliance lifted its holdings in IQVIA by 4.2% in the first quarter. Independent Advisor Alliance now owns 1,801 shares of the medical research company’s stock valued at $318,000 after acquiring an additional 72 shares during the period. Finally, Nemes Rush Group LLC lifted its holdings in IQVIA by 15.0% in the first quarter. Nemes Rush Group LLC now owns 621 shares of the medical research company’s stock valued at $109,000 after acquiring an additional 81 shares during the period. 89.62% of the stock is owned by institutional investors.

IQVIA Stock Performance

Shares of IQV opened at $220.64 on Friday. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 2.45. The business has a 50-day simple moving average of $194.47 and a two-hundred day simple moving average of $171.27. The stock has a market cap of $37.51 billion, a price-to-earnings ratio of 31.93, a PEG ratio of 2.42 and a beta of 1.32. IQVIA Holdings Inc. has a 52 week low of $134.65 and a 52 week high of $225.91.

IQVIA (NYSE:IQV) last released its earnings results on Tuesday, July 22nd. The medical research company reported $2.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.77 by $0.04. IQVIA had a return on equity of 30.05% and a net margin of 7.88%.The firm had revenue of $4.02 billion during the quarter, compared to analysts’ expectations of $3.96 billion. During the same quarter last year, the business posted $2.64 earnings per share. The firm’s revenue was up 5.3% on a year-over-year basis. On average, analysts expect that IQVIA Holdings Inc. will post 10.84 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on IQV. HSBC raised IQVIA from a “hold” rating to a “buy” rating and increased their target price for the company from $195.00 to $235.00 in a report on Thursday, October 9th. Hsbc Global Res raised IQVIA from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 9th. William Blair reissued an “outperform” rating on shares of IQVIA in a report on Wednesday, July 23rd. UBS Group upped their price target on IQVIA from $185.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Finally, Redburn Partners set a $214.00 price target on IQVIA in a research report on Wednesday, September 3rd. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $234.57.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.